undamentalytics Newsletter

TechnipFMC vs NOV

TechnipFMC and NOV are similar in size: $9.93bn and $8.74bn of revenue in their latest fiscal years. TechnipFMC grew faster (9.4% against -1.4%). TechnipFMC kept more of each dollar of sales as profit: a net margin of 9.7% against 1.7%. TechnipFMC carries less debt relative to equity (12.8% against 27.6%).

Latest fiscal yearTechnipFMCFTI, 2025NOVNOV, 2025
Revenue $9.93bn $8.74bn
Revenue growth 9.4% -1.4%
Net income $964m $145m
Operating margin 14.5% 5.6%
Net margin 9.7% 1.7%
Return on equity 29.9% 2.3%
Free cash flow $1.45bn $876m
Cash $1.03bn $1.55bn
Total debt $430m $1.73bn
Debt to equity 12.8% 27.6%
Dividend per share $0.20 $0.51
Dividend yield 0.3% 2.3%
Share buybacks $918m $315m
Employees 22,000 —
Market value $26.24bn $6.67bn
Price vs our value range Below our value range Below our value range
Moat score 39 (Weak) 32 (Weak)
Insider trades, 12 months 1 buys, 21 sales 2 buys, 6 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.